Project description
Norgine is a European specialty pharmaceutical company, headquartered in Amsterdam, with roots dating back to 1906. It has around 1,500 employees and roughly €650 million in annual sales, and it targets unmet medical needs from common conditions like constipation to rare and severe diseases such as childhood cancer. Its therapeutic focus spans hepatology, oncology, women's health and gastroenterology. Norgine's integrated model covers acquiring, developing and commercialising medicines, backed by in-house manufacturing in Wales and France.